雙財莊(2321.HK)首日上市高開42.86%
格隆匯8月19日丨馬來西亞老牌食品飲料分銷商雙財莊(2321.HK)首日上市高開42.86%報0.8港元,最新市值7.71億港元。該股此次IPO以招股價上限0.56港元定價。雙財莊是一家馬來西亞食品與飲料的知名分銷商,分銷奧利奧、吉百利、味之素等第三方品牌,擁有逾1.1萬名活躍客户;亦為供應商提供倉儲、物流、銷售及營銷支持以及其他增值服務。財務數據顯示,公司2021財年收益6.69億令吉,同比增長25%,年內溢利2358.8萬令吉。今年前四個月營收2.67億令吉,溢利1192.6萬令吉。(1令吉≈1.52人民幣)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.